Neonatal hypovolemic shock

Neonatal hypovolemic shock represents a critical, life-threatening condition in newborns, distinguished by inadequate perfusion due to acute intravascular volume loss. Although not as common as in older pediatric populations, significant etiologies include fetomaternal hemorrhage, abruptio placentae, severe dehydration, or occult blood loss such as massive subgaleal or intra-abdominal hemorrhage. Early recognition is paramount, yet challenging-clinical signs often emerge in the uncompensated phase, with hypotension, lactic acidosis, poor perfusion, and oliguria indicating imminent multiorgan dysfunction. Vital diagnostic clues include pallor, tachycardia, prolonged capillary refill, and metabolic derangements; lactic acidemia and low hemoglobin may point toward hemorrhagic causes such as subgaleal hematoma. Management hinges on prompt intravascular volume restoration. Initial resuscitation typically includes isotonic crystalloid boluses (e.g., normal saline ۱۰-۲۰ mL/kg), with repetition as needed. In hemorrhagic scenarios, rapid blood transfusion is essential; fresh frozen plasma may be required if coagulopathy is present. Adjunctive measures include inotropic support such as dopamine or dobutamine when fluid alone is insufficient-while dopamine may more effectively raise blood pressure, dobutamine augments systemic blood flow, especially in premature infants. Functional echocardiography and near-infrared spectroscopy could assist hemodynamic assessment but lack definitive evidence linking them to improved outcomes. In summary, neonatal hypovolemic shock demands early identification, aggressive volume resuscitation, transfusions when indicated, and judicious use of inotropes to optimize perfusion. Despite advances, high-quality evidence remains limited, highlighting the need for further research into diagnostic modalities and long-term outcomes.